Landmark Japanese Study Maps Survival Odds for Gastric Cancer Before Treatment Begins
A six-year follow-up of more than 1,100 Japanese gastric cancer patients provides the first long-term survival figures stratified by clinical ...
A six-year follow-up of more than 1,100 Japanese gastric cancer patients provides the first long-term survival figures stratified by clinical ...
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...
A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...
A multicenter real-world study of 465 patients found that adding brain radiotherapy to first-line third-generation EGFR inhibitors improved survival in ...
A small Turkish retrospective study found the MSKCC nomogram discriminated survival better than Sarculator in extremity soft tissue sarcoma, though ...
A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...
Researchers built an explainable random survival forest model that predicts overall and cancer-specific survival in postoperative gastrointestinal stromal tumor patients, ...
A propensity score-matched study of 153 patients suggests adjuvant radiotherapy does not improve overall or recurrence-free survival in limb liposarcoma, ...
A ten-year single-center study reports 94 percent primary efficacy and 100 percent cancer-specific survival at five years for image-guided ablation ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine